These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7970613)

  • 1. Crystallization test for the detection of head and neck cancer.
    Gulati SP; Sachdeva OP; Sachdeva A; Adlakha RP; Kakkar V
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):283-6. PubMed ID: 7970613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crystallization test in patients with head and neck neoplasms].
    Kuczkowski J; Zaorski P; Betlejewski A
    Otolaryngol Pol; 1995; 49 Suppl 20():121-4. PubMed ID: 9454116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of crystallization test for screening of oral squamous cell carcinoma with clinico-pathological correlation.
    Sarode SC; Sarode GS; Barpande S; Tupkari JV
    Indian J Dent Res; 2013; 24(4):464-7. PubMed ID: 24047839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of crystallization test in screening of potentially malignant oral disorders and oral cancer.
    Tarigoppula RKVN; Ahmed Mujib BR; Naik R
    Indian J Dent Res; 2018; 29(5):556-561. PubMed ID: 30409932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck].
    Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
    Pol Merkur Lekarski; 2001 Oct; 11(64):320-2. PubMed ID: 11770310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insight into crystallization test: A neoteric approach for screening premalignant and malignant lesions.
    Rawat G; Kureel K; Urs AB
    J Cancer Res Ther; 2020; 16(3):440-444. PubMed ID: 32719248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco influence in heavy metals levels in head and neck cancer cases.
    Bandeira CM; de Almeida AÁ; Carta CFL; Almeida AA; de Figueiredo FAT; Sandrim VC; Gonçalves AJ; Almeida JD
    Environ Sci Pollut Res Int; 2018 Sep; 25(27):27650-27656. PubMed ID: 30056540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum magnesium levels in patients with head and neck cancer.
    Kohli GS; Bhargava A; Goel H; Yadav SP; Saini AS; Singh GP; Lal H
    Magnesium; 1989; 8(2):77-86. PubMed ID: 2755215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYFRA 8/18 in head and neck cancer.
    Maass JD; Niemann AM; Lippert BM; Gottschlich S; Folz BJ; Werner JA
    Anticancer Res; 1999; 19(4A):2699-701. PubMed ID: 10470223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of platelet aggregation in patients with malignant tumor of the head and neck].
    Nong HT
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):454-7. PubMed ID: 8200287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Proteasomes in the Pathogenesis of Head and Neck Squamous Cell Carcinoma.
    Kakurina GV; Cheremisina OV; Choinzonov EL; Kondakova IV
    Bull Exp Biol Med; 2017 May; 163(1):92-94. PubMed ID: 28577090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
    Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace metals and total antioxidant potential in head and neck cancer patients.
    Akinmoladun VI; Owotade FJ; Olusanya AA
    Ann Afr Med; 2013; 12(2):131-4. PubMed ID: 23713022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
    Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
    Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
    Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.